Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study - Concepedia

Concepedia

Publication | Open Access

Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study

DOI Full Paper Access

368

Citations

32

References

2018

Year

Jan W. Eriksson, Per Lundkvist, Per‐Anders Jansson, L. E. B. Johansson, Mats Kvarnström, Linda Moris, Tasso Miliotis, Gun‐Britt Forsberg, Ulf Risérus, Lars Lind,

Abstract

ClinicalTrials.gov NCT02279407 FUNDING: The study was funded by AstraZeneca.

References

	Year	Citations
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes Bernard Zinman, Christoph Wanner, John M. Lachin, New England Journal of Medicine	2015	11.6K
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes Bruce Neal, Vlado Perkovic, Kenneth W. Mahaffey, New England Journal of Medicine	2017	7.5K
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease Stefano Romeo, Julia Kozlitina, Chao Xing, Nature Genetics Metabolic SyndromeHepatologyGeneticsLiver PhysiologyGenetic Epidemiology	2008	3.3K
The NAFLD fibrosis score Paul Angulo, Jason M. Hui, Giulio Marchesini, Hepatology	2007	3.1K
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial Brent A. Neuschwander‐Tetri, Rohit Loomba, Arun J. Sanyal, The Lancet HepatologyMedicineLiver PhysiologyPathologyPlacebo-controlled Trial	2014	2.2K
Mitochondrial Overload and Incomplete Fatty Acid Oxidation Contribute to Skeletal Muscle Insulin Resistance Timothy R. Koves, John R. Ussher, Robert C. Noland, Cell Metabolism Metabolic SyndromeEnergy MetabolismMitochondrial FunctionBiochemistryDiabetes	2008	1.9K
Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients Ele Ferrannini, Elza Muscelli, Silvia Frascerra, Journal of Clinical Investigation	2014	1.1K
Adaptation of Hepatic Mitochondrial Function in Humans with Non-Alcoholic Fatty Liver Is Lost in Steatohepatitis Chrysi Koliaki, Julia Szendroedi, Kirti Kaul, Cell Metabolism PathologyFatty Liver DiseaseOxidative StressMetabolic SyndromeHepatic Mitochondrial Function	2015	975
Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs Mikhail Kosiborod, Matthew A. Cavender, Alex Z. Fu, Circulation	2017	791
Plasma Acylcarnitine Profiles Suggest Incomplete Long-Chain Fatty Acid β-Oxidation and Altered Tricarboxylic Acid Cycle Activity in Type 2 Diabetic African-American Women Sean H. Adams, Charles L. Hoppel, Kerry H. Lok, Journal of Nutrition Metabolic SyndromePhysiologyDiabetesType 2Diabetic African-american Women	2009	594

Page 1